COVID-19 UPDATES

Innovaderm continues to focus on the well-being and safety of our employees and patients, supporting business continuity for us and our customers, and ensuring that our studies continue to be conducted in compliance with applicable regulations.   Innovaderm continues to follow Health Canada, regional authorities, and Centers for Disease Control (CDC) guidance. Following the latest […].. Read more

COVID-19 UPDATES

Innovaderm is following Health Canada, regional authorities, and Centers for Disease Control (CDC) guidance. Following the latest announcement by the Quebec Government requesting all non-essential businesses to close their offices to facilitate the enforcement of social distancing until April 13, 2020, our headquarters offices are closed since March 24th, 2020, without major impact on our […].. Read more

COVID-19 UPDATES

Innovaderm is following Health Canada and Centers for Disease Control (CDC) guidance and is recommending to all CRO Operations employees able to work from home to do so immediately until further notice. Where possible, public transit, air and rail travel will be discouraged in regions with known outbreaks.   Innovaderm will continue to review our […].. Read more

COVID-19 UPDATES

In light of the current global situation with COVID-19, Innovaderm’s focus is on the well-being and safety of our employees and patients, supporting business continuity for us and our customers, and ensuring that our studies continue to be conducted in compliance with applicable regulations. We are surveying health authorities, and we will continue to monitor this […].. Read more